Melanoma Research

Papers
(The H4-Index of Melanoma Research is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety18
Development and validation of prognostic nomogram in pediatric melanoma: a population-based study17
Clinical features, molecular characteristics and surgical management of primary penile mucosal melanoma based on the European Association of Urology Penile Cancer Guidelines16
Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors16
Causal relationship between sex hormones and cutaneous melanoma: a two-sample Mendelian randomized study15
Aseptic cystitis induced by nivolumab and ipilimumab combination for metastatic melanoma14
Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanoma12
Ponatinib-induced eruptive nevi and melanocytic proliferation11
Histopathological and immunological spectrum in response evaluation of talimogene laherparepvec treatment and correlation with durable response in patients with cutaneous melanoma10
Eruptive melanocytic nevi in a patient with amelanotic melanoma: a paraneoplastic phenomenon?10
Rare immune-related adverse events in a patient with metastatic melanoma: a case report highlighting sarcoidosis-like reactions triggered by immune-checkpoint inhibitors10
Polymorphisms in toll-like receptor 3 and 4 genes as prognostic and outcome biomarkers in melanoma patients10
Prognosis of CDKN2A germline mutation in patients with familial melanoma: a systematic review and meta-analysis10
Efficacy of topical diphencyprone for melanoma in-transit metastases: a systematic review and meta-analysis10
Treatment reality of patients with BRAF-mutant advanced/metastatic melanoma in Switzerland in the era of choice10
Telomere length is associated with increased risk of cutaneous melanoma: a Mendelian randomization study10
0.05698299407959